00889nas a2200361   4500000000100000000000100001008004100002653001100043653001700054653001600071653001300087653001600100653001800116100001800134700001200152700001600164700001300180700001000193700002100203700001700224700001600241700002400257700001300281700002100294700001400315700001200329700001200341245009900353250001500452300002200467490000700489020003100496       2022                            d10aEurope10aconstipation10adrug misuse10airritab)10alinaclotide10aoff-label use1 aJ. Cid-Ruzafa1 aB. Lacy1 aA. Schultze1 aM. Duong1 aY. Lu1 aM. Raluy-Callado1 aR. Donaldson1 aD. Weissman1 aA. Gómez-Lumbreras1 aD. Ouchi1 aM. Giner-Soriano1 aR. Morros1 aA. Ukah1 aD. Pohl00aLinaclotide utilization and potential for off-label use and misuse in three European countries  a2022/06/17  a175628482211009460 v15  a1756-283X (Print)1756-283x